Akums Drugs and Pharmaceuticals Competitors and Similar CompaniesClear all

Akums Drugs and Pharmaceuticals's competitors and similar companies include Pharmaron, Hypera Pharma, Innovent Biologics and Bausch Health Americas.

	Akums Drugs and Pharmaceuticals Akums Drugs and Pharmaceuticals is a contract development and manufacturing organization (CDMO).	Pharmaron Pharmaron (康龙化成(北京)新药技术股份有限公司) is a company that provides drug research, development, and manufacturing services for the life sciences industry.	Hypera Pharma Hypera Pharma is a pharmaceutical company that provides medicines and food supplements.	Innovent Biologics Innovent Biologics is a biopharmaceutical company that develops and manufactures drugs.	Bausch Health Americas Bausch Health Americas (BHA) is a pharmaceutical preparation manufacturing company.
Founding Date	Founding Date 2004	Founding Date 2004	Founding Date 2001	Founding Date 2011	Founding Date 1994
Type	Type Private	Type Public	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare drug development pharma	Tags Healthcare biotech clinical research drug development pharma therapy	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial drug development pharma
Locations	Locations Delhi, IN HQ Delhi, IN	Locations Beijing, CN HQ Beijing, CN Nanjing, CN Ningbo, CN Shanghai, CN Tianjin, CN Xi'an, CN see more	Locations São Paulo, BR HQ	Locations Suzhou, CN HQ	Locations Bridgewater, US HQ Laval, CA Steinbach, CA Envigado, CO La Estrella, CO Medellín, CO Ciudad De México, MX see more
Employees	Employees 4,4829% increase	Employees 21,370	Employees 10,481	Employees 5,659	Employees 4,044
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥13.9b (FY, 2025)	Revenue (est.) R$7.7b (FY, 2025)	Revenue (est.) ¥13b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ¥9.2b (FY, 2025)	Cost of goods R$2.8b (FY, 2025)	Cost of goods ¥1.1b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ¥4.8b (FY, 2025)	Gross profit R$4.9b (FY, 2025)	Gross profit ¥12b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ¥1.6b (FY, 2025)	Net income R$1.2b (FY, 2025)	Net income ¥813.6m (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 70m	Total funding raised $ 909m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A